Skip to main content
OpenTrials
Completed

NCT Number: NCT02589197

Gait and Functional Outcomes Study Following Total Knee Arthroplasty With Medial-pivot or Posterior-stabilized Implants

MicroPort Orthopedics (MPO) is conducting this study to build upon the results of a previous study which showed the Medial Pivot (MP) system required lower quadriceps activation than subjects implanted with a Posterior stabilized (PS) system preforming the same activities of daily living.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–76 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The Ottawa Hospital, Ottawa, Ontario, Canada

Loading trial locations.

About this study

MicroPort Orthopedics (MPO) is conducting this study to build upon the results of a previous study which showed the Medial Pivot (MP) system required lower quadriceps activation than subjects implanted with a Posterior stabilized (PS) system preforming the same activities of daily living. The propose of the current study is to determine the impact of Total Knee Arthroplasty (TKA) design on muscle activation following TKA surgery.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

To be included in Groups 1 and 2, subjects must meet all of the following criteria:

Subject is a candidate for unilateral primary TKA for degenerative or traumatic osteoarthritis Subject is a candidate to be implanted with the specified combination of components for either Group 1 or 2 Subjects are at least 45 years old and less than 76 years of age at time of enrollment Subject is willing and able to complete required study visits and assessments Subject plans to be available through the 1 year postoperative follow-up visit Subject is willing to sign the approved Informed Consent document

To be included in Group 3, subjects must meet all of the following criteria:

Subjects are at least 45 years old and less than 76 years of age at time of enrollment Subject is willing and able to complete required study visit and assessments Subject is willing to sign the approved Informed Consent document

Exclusion criteria

Subjects will be excluded if they meet any of the following criteria:

Subject has both a body mass index (BMI) and waist circumference measurements greater than 35.0 kg/m2 and 102.0 cm respectively for men and 35.0 kg/m2 and 88.0 cm respectively for women at screening.

Groups 1 & 2 Only: Subject has degenerative conditions (other than osteoarthritis in the enrolled TKA) impacting joints of the lower extremities, previous joint replacement of the enrolled knee or other lower limb joint replacement, or any other past or present condition, which in the opinion of the Investigator may impact gait. Group 3 Only: Subject has degenerative condition impacting joints of the lower extremities, any previous joint replacement in the knees, or any other past or present condition, which in the opinion of the Investigator may impact gait.

Groups 1 and 2 Only: Subjects with a Kellgren-Lawrence Grading Scale of ≥2 on the contralateral knee if having severe pain or abnormal gait patterns.

Subject is currently enrolled in another clinical investigation related to lower limbs which could affect the endpoints of this protocol.

Subject is unwilling or unable to sign the Informed Consent document Subject has documented substance abuse issues Subject has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study Subject is currently incarcerated or has impending incarceration

Treatment and study plan

Group 1 (Medial-Pivot)

Device

EVOLUTION® Total Knee Arthroplasty Medial Pivot system with CS inserts

Other names: EVOLUTION® CS TKA System, Total Knee Arthroplasty Sytem, EVOLUTION®

Group 2 (Posterior-Stabilized)

Device

Zimmer® NexGen® Total Knee Arthroplasty system with PS inserts

Other names: Zimmer® NexGen® PS TKA System, Total Knee Arthroplasty Sytem, NexGen®

Primary outcomes

  1. Lower Limb Muscle Activation Comparison as Assessed by Maximum Voluntary Isometric Contraction Muscle Strength and Dynamic Muscle Activation Measurements in Total Knee Arthroplasty Subjects Implanted with Medial-pivot or Posterior-stabilized Implants

    Time frame: Presurgery and 12 Months Post Surgery

    Measured by Dynamic Muscle Activation Measurements and Maximum Voluntary Isometric Contraction Muscle Strength and Activation

Secondary outcomes

  1. Compare lower limb muscle activation between the control group (Group 3) and Groups 1 and 2, as assessed by maximum voluntary isometric contraction muscled strength and dynamic muscle activation measurements

    Time frame: Presurgery and 12 Months Post Surgery for implanted subjects

    Measured by Dynamic Muscle Activation Measurements and Maximum Voluntary Isometric Contraction Muscle Strength and Activation

  2. Compare functional outcomes for the Groups 1 and 2 as assessed by the Timed Up & Go (TUG) test

    Time frame: Presurgery and 12 Months Post Surgery for implanted subjects

    Measured by Timed Up & Go (TUG) test

  3. Compare functional outcomes for the Groups 1 and 2 as assessed by the KOOS Scores

    Time frame: Presurgery and 12 Months Post Surgery for implanted subjects

    Measured by KOOS Scores

  4. Compare subject satisfaction using a custom five question patient satisfaction questionnaire for Groups 1 and 2

    Time frame: 12 Months Post Surgery

    Measured by Patient Satisfaction Survey

Sponsors and collaborators

Lead sponsor

MicroPort Orthopedics Inc.

Industry

Collaborators

  • The Ottawa Hospital
  • University of Ottawa

Registry information

Official study title

Muscle Activation and Biomechanical Function of the Lower-limb Joints Following Total Knee Arthroplasty With Medial-pivot or Posterior-stabilized Implants: an Electromyography Study

Acronym: GOLD

Important dates

Study start
2016
Primary completion
2022
Study completion
2022
First posted
Oct 28, 2015
Registry last updated
Nov 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.